Private Equity
The acquisition complements Symeres’ drug discovery capabilities with biology and biophysics capabilities in oncology.
1 min read · 10 January 2023
The backers include CVS Health, Cigna Ventures, Humana, Memorial Hermann Health System, SCAN, TPG Capital, Frist Cressey Ventures, Heritage Group, Pura Vida Investments, and Norwest Venture Partners.
1 min read · 10 January 2023
First Analysis Securities Corp. acted as financial advisor to COPILOT.
1 min read · 10 January 2023
Harris Williams served as financial advisor to InterMed on the deal.
1 min read · 09 January 2023
The deal is valued at $900 million.
1 min read · 09 January 2023
Proteros focuses on early-stage drug discovery and works with companies in Europe, the US and Japan.
2 min read · 09 January 2023
AVS Bio is a provider of specific pathogen free eggs, lab products and services that support the development and manufacture of vaccines and treatments for human and animal health.
1 min read · 06 January 2023
U.S. Urology Partners is a provider of urology and other specialty services.
1 min read · 06 January 2023
Stericare is a maker of medical water products.
1 min read · 06 January 2023
Help at Home is a national provider of home care services.
1 min read · 05 January 2023